Lithium and Neuropsychiatric Therapeutics : Neuroplasticity via Glycogen Synthase Kinase-3β, β-Catenin, and Neurotrophin Cascades
スポンサーリンク
概要
- 論文の詳細を見る
Mood disorders are not merely attributed to the functional defect of neurotransmission, but also are due to the structural impairment of neuroplasticity. Chronic stress decreases neurotrophin levels, precipitating or exacerbating depression; conversely, antidepressants increase expression of various neurotrophins (e.g., brain-derived neurotrophic factor and vascular endothelial growth factor), thereby blocking or reversing structural and functional pathologies via promoting neurogenesis. Since the worldwide approval of lithium therapy in 1970, lithium has been used for its anti-manic, antidepressant, and anti-suicidal effects, yet the therapeutic mechanisms at the cellular level remain not-fully defined. During the last five years, multiple lines of evidence have shown that the mood stabilization and neurogenesis by lithium are due to the lithium-induced inhibition of glycogen synthase kinase-3β (GSK-3β), allowing accumulation of β-catenin and β-catenin–dependent gene transcriptional events. Altered levels of GSK-3β and β-catenin are associated with various neuropsychiatric and neurodegenerative diseases, while various classical neuropsychiatric drugs inhibit GSK-3β and up-regulate β-catenin expression. In addition, evidence has emerged that insulin-like growth factor-I enhances antidepression, anti-anxiety, memory, neurogenesis, and angiogenesis; antidepressants up-regulate expression of insulin-like growth factor-I, while insulin-like growth factor-I up-regulates brain-derived neurotrophic factor expression and its receptor TrkB level, as well as brain-derived neurotrophic factor-induced synaptic protein levels. More importantly, physical exercise and healthy diet raised transport of peripheral circulating insulin-like growth factor I into the brain, reinforcing the expression of neurotrophins (e.g., brain-derived neurotrophic factor) and the strength of cell survival signalings (e.g., phosphoinositide 3-kinase / Akt / GSK-3β pathway). This review will focus on the rapidly advancing new trends in the last five years about lithium, GSK-3β/β-catenin, and neurotrophin cascades.
- 2009-05-20
著者
関連論文
- Roles of Voltage-Dependent Sodium Channels in Neuronal Development, Pain, and Neurodegeneration
- Detection of Brain Metastasis: Comparison of Turbo-FLAIR Imaging, T_2-weighted Imagig and Double-dose Gadolinium-enhanced MR Imaging
- Lithium : Potential Therapeutics Against Acute Brain Injuries and Chronic Neurodegenerative Diseases
- A study on the beryllium lymphocyte transformation test and the beryllium levels in working environment
- New Twist on Neuronal Insulin Receptor Signaling in Health, Disease, and Therapeutics
- Molecular Mechanisms and Drug Development in Aquaporin Water Channel Diseases : Aquaporins in the Brain
- ENDOTHELIUM-INDEPENDENT VASORELAXATION INDUCED BY ACETYLCHOLINE
- Inhibition by Selenium Compounds of Catecholamine Secretion Due to Inhibition of Ca^ Influx in Cultured Bovine Adrenal Chromaffin Cells
- Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway : The Role of GSK-3β in the Maintenance of Steady-State Levels of Insulin Receptor Signaling Molecules and Na_v1.7 Sodium Channel in Adrenal Chromaffi
- Brain Activation during the Spot the Differences Game
- Lithium and Neuropsychiatric Therapeutics : Neuroplasticity via Glycogen Synthase Kinase-3β, β-Catenin, and Neurotrophin Cascades
- Enlargement of the Hippocampal Angle : A New Index of Alzheimer Disease
- Magnetic Resonance Imaging(MRI)and Technetium-99m-methoxyisonitrile(MIBI)Scintigraphy to Evaluate the Abnormal Parathyroid Gland and PEIT Efficacy for Secondary Hyperparathyroidism
- Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts : Report of a Case and Review of the Literature
- ACTIVATION BY PHOSPHOLIPASE A2 OF THE CATECHOLAMINE RELEASE FROM ISOLATED CHROMAFFIN GRANULES
- Dexmedetomidine and clonidine inhibit the function of Na_v1.7 independent of α_2-adrenoceptor in adrenal chromaffin cells
- MR Imaging of Uterine Adenosarcoma : Case Report and Literature Review
- Pathophysiological function of adrenomedullin and proadrenomedullin N-terminal peptides in adrenal chromaffin cells